Tuberculosis

'Coca-Cola' model for delivering malaria meds is a success, researcher says

(Medical Xpress)—A controversial program that uses the private market to provide affordable malaria treatments to people in Africa has dramatically increased access to care and should be continued, according to a policy article by scholars including Ramanan Laxmin ...

Medications created Nov 13, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

India wages hi-tech war on ancient TB scourge

(AP)—Shammo Khan walks into a dusty courtyard that reeks of garbage, searching for the fingerprint of a man exhausted by HIV, drug withdrawal and the tuberculosis lesions hijacking his lungs.

Diseases, Conditions, Syndromes created Nov 11, 2012 | popularity not rated yet | comments 0

UK funding for infectious disease research neglects key areas of disease

The research undertaken by researchers at University College, Imperial College, and the London School of Hygiene and Tropical Medicine is the first ever detailed assessment of infectious diseases investments made by funding ...

Diseases, Conditions, Syndromes created Nov 08, 2012 | popularity not rated yet | comments 0

Molecular epidemiological conditions relating to tuberculous and non-tuberculous mycobacteria

A research project has been studying the molecular epidemiological conditions relating to diseases caused by tuberculous and non-tuberculous mycobacteria in the Mubende region of Uganda.

Diseases, Conditions, Syndromes created Nov 08, 2012 | popularity not rated yet | comments 0

Xeljanz approved for rheumatoid arthritis

(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.

Arthritis & Rheumatism created Nov 07, 2012 | popularity not rated yet | comments 0

New DNA vaccine technology poised to deliver safe and cost-effective disease protection

New and increasingly sophisticated vaccines are taking aim at a broad range of disease-causing pathogens, targeting them with greater effectiveness at lower cost and with improved measures to ensure safety.

Medical research created Nov 05, 2012 | popularity 4.8 / 5 (4) | comments 5 | with audio podcast

Mass spectrometry helps researchers 'watch' how antibiotics attack tuberculosis bacteria inside cells

Weill Cornell Medical College researchers report that mass spectrometry, a tool currently used to detect and measure proteins and lipids, can also now allow biologists to "see" for the first time exactly how drugs work inside ...

Medical research created Nov 01, 2012 | popularity not rated yet | comments 0 | with audio podcast

Officials debate whether to scrap malaria program

The future of a pricey malaria program meant to provide cheap drugs for poor patients may be in jeopardy after health officials clashed over its effectiveness in two new reports.

Diseases, Conditions, Syndromes created Oct 31, 2012 | popularity not rated yet | comments 0

Asia battles drug-resistant malaria

Drug-resistant malaria is spreading in Asia, experts warned as a high-level conference opened Wednesday with the aim of hammering out an action plan to strengthen the region's response.

Diseases, Conditions, Syndromes created Oct 31, 2012 | popularity not rated yet | comments 0

New genetic links for inflammatory bowel disease uncovered

Crohn's disease (CD) and ulcerative colitis (UC) – inflammatory diseases of the gastrointestinal tract – have puzzled the scientific community for decades. Ten years ago, researchers recognized that both genes and the ...

Genetics created Oct 31, 2012 | popularity not rated yet | comments 0 | with audio podcast

Scientists to study the role genes play in treating tuberculosis

The University of Liverpool has been awarded funding to determine whether differences in our genes determine how patients respond to drugs used to treat Tuberculosis (TB) in Sub-Saharan Africa.

Genetics created Oct 25, 2012 | popularity not rated yet | comments 0 | with audio podcast

Next-generation vaccines—eliminating the use of needles

Lead scientist Professor Simon Cutting, from the School of Biological Sciences at Royal Holloway, has developed the jabs through the use of probiotic spores. He carried out fundamental studies into the biology of the bacterium ...

Medications created Oct 23, 2012 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Technology brings new life to the study of diseases in old bones

A study led by The University of Manchester has demonstrated that new technology that can analyse millions of gene sequences in a matter of seconds is an effective way to quickly and accurately identify diseases in skeletons.

Medical research created Oct 22, 2012 | popularity not rated yet | comments 0 | with audio podcast

Antibiotic shows promise in treating extensively drug-resistant tuberculosis

When tested in patients hospitalized with extensively drug-resistant tuberculosis (XDR-TB) unresponsive to previous treatment, linezolid, an antibiotic used to treat severe bacterial infections, proved largely effective when ...

Diseases, Conditions, Syndromes created Oct 18, 2012 | popularity not rated yet | comments 0

TB fight making progress, but more funds needed, WHO reports

The war on tuberculosis is getting new weapons for the first time in decades, offering hope for controlling the deadly disease but major funding shortfalls threaten progress, the World Health Organization said Wednesday.

Diseases, Conditions, Syndromes created Oct 17, 2012 | popularity not rated yet | comments 0


Tuberculosis, MTB, or TB (short for tubercle bacillus) is a common, and in many cases lethal, infectious disease caused by various strains of mycobacteria, usually Mycobacterium tuberculosis. Tuberculosis usually attacks the lungs but can also affect other parts of the body. It is spread through the air when people who have an active MTB infection cough, sneeze, or otherwise transmit their saliva through the air. Most infections in humans result in an asymptomatic, latent infection, and about one in ten latent infections eventually progress to active disease, which, if left untreated, kills more than 50% of those infected.

The classic symptoms are a chronic cough with blood-tinged sputum, fever, night sweats, and weight loss (the last giving rise to the formerly prevalent colloquial term "consumption"). Infection of other organs causes a wide range of symptoms. Diagnosis relies on radiology (commonly chest X-rays), a tuberculin skin test, blood tests, as well as microscopic examination and microbiological culture of bodily fluids. Treatment is difficult and requires long courses of multiple antibiotics. Social contacts are also screened and treated if necessary. Antibiotic resistance is a growing problem in (extensively) multi-drug-resistant tuberculosis. Prevention relies on screening programs and vaccination, usually with Bacillus Calmette-Guérin vaccine.

One third of the world's population is thought to have been infected with M. tuberculosis, and new infections occur at a rate of about one per second. In 2007 there were an estimated 13.7 million chronic active cases, and in 2010 8.8 million new cases, and 1.45 million deaths, mostly in developing countries. The absolute number of tuberculosis cases has been decreasing since 2006 and new cases since 2002. In addition, more people in the developing world contract tuberculosis because their immune systems are more likely to be compromised due to higher rates of AIDS. The distribution of tuberculosis is not uniform across the globe; about 80% of the population in many Asian and African countries test positive in tuberculin tests, while only 5–10% of the U.S. population test positive.

This text uses material from Wikipedia and is available under the GNU Free Documentation License.

Latest Spotlight News

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.

Brain can be trained in compassion, study shows

Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.

Do salamanders hold the solution to regeneration?

Salamanders' immune systems are key to their remarkable ability to regrow limbs, and could also underpin their ability to regenerate spinal cords, brain tissue and even parts of their hearts, scientists have ...

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Multiple research teams unable to confirm high-profile Alzheimer's study

Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.

The compound in the Mediterranean diet that makes cancer cells 'mortal'

New research suggests that a compound abundant in the Mediterranean diet takes away cancer cells' "superpower" to escape death. By altering a very specific step in gene regulation, this compound essentially re-educates cancer ...

Brain uses internal 'average voice' prototype to identify who is talking

(Medical Xpress)—The human brain is able to identify individuals' voices by comparing them against an internal 'average voice' prototype, according to neuroscientists.

Motion quotient: IQ predicted by ability to filter motion (w/ video)

A brief visual task can predict IQ, according to a new study. This surprisingly simple exercise measures the brain's unconscious ability to filter out visual movement. The study shows that individuals whose ...

Controlling mood through the motions of mitochondria

(Medical Xpress)—Regulating the distribution of power in neurons is done by a system that makes the national electric grid look simple by comparison. Each neuron has several thousand mitochondria confined ...

Slowing the aging process—only with antibiotics

Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.